NCT03663777

Brief Summary

The aim of this study is to analyze the effects of isometric handgrip training (IHT) on blood pressure of hypertensive patients with peripheral arterial disease. Will be recruited 30 patients which will be randomized into 2 groups (15 per group), IHT and control group (CG). IHT group will training isometric contraction for 12 weeks. In CG patients will be encouraged to increase the level of physical activity. In the pre and post-intervention cardiovascular measures will be obtained.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
20mo left

Started Aug 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Aug 2018Dec 2027

Study Start

First participant enrolled

August 1, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 5, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 10, 2018

Completed
9.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2027

Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

9.4 years

First QC Date

September 5, 2018

Last Update Submit

April 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in blood pressure at 12 weeks

    Blood pressure will be measured before and after 12 weeks of intervention period on intervention and control group by an automatic blood pressure monitor (HEM-742, Omron Healthcare, Japan).

    Baseline and 12 weeks

Secondary Outcomes (1)

  • Change from baseline in cardiac autonomic modulation at 12 weeks

    Baseline and 12 weeks

Study Arms (2)

Isometric Handgrip Training

EXPERIMENTAL

Experimental group will perform home-based bilaterall handgrip exercise and will be recommended to increase daily physical activity levels.

Other: Isometric handgrip training

Control group

OTHER

Control gorup will be recommended to increase daily physical activity level

Other: Control Group

Interventions

Intervention period will last 12 weeks. Experimental group will perform three sessions per week of home-based handgrip exercise. The exercise protocol will consist of eight sets of bilateral handgrip contraction of two minutes of isometric contraction, with 30% of maximum voluntary contraction, and two minutes of interval between sets. Patients will receive a diary to record the sessions and report difficulties during the training. The patients be recommended to increase daily physical activity levels, and weekly, there will be phone contacts with the patients to reinforce the exercise recommendations.

Also known as: Isometric resistance exercise
Isometric Handgrip Training

Intervention period will last 12 weeks. Patients will be recommended to increase daily physical activity levels, and weekly, there will be phone contacts to reinforce the recommendations.

Control group

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women in post-menopause phase without hormone replacement therapy
  • Ankle-brachial index \<0.90
  • Not severe obese (≥ 35kg/m2)
  • Not present amputation in the limbs
  • Have blood pressure levels lower than 160mmHg for systolic and 105mmHg for diastolic

You may not qualify if:

  • patients will only be excluded if they make any medication changes before completing the intervention period or present any health problems that prevent physical activity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Universidade Nove de Julho

São Paulo, São Paulo, 01525-000, Brazil

RECRUITING

Hospital Israelita Albert Einstein

São Paulo, São Paulo, 05652-900, Brazil

COMPLETED

MeSH Terms

Conditions

Peripheral Arterial Disease

Interventions

Control Groups

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Raphael Dias, PhD

    University of Nove de Julho

    PRINCIPAL INVESTIGATOR
  • Marilia Correia, PhD

    University of Nove de Julho

    STUDY CHAIR

Central Study Contacts

Raphael Dias, PhD

CONTACT

Marilia Correia, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 5, 2018

First Posted

September 10, 2018

Study Start

August 1, 2018

Primary Completion (Estimated)

December 30, 2027

Study Completion (Estimated)

December 30, 2027

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

WE plan to share the data upon requirement

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
After 1 year after the end of recruitment

Locations